Correlation Between OliX PharmaceuticalsI and Green Cross

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OliX PharmaceuticalsI and Green Cross at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OliX PharmaceuticalsI and Green Cross into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OliX PharmaceuticalsInc and Green Cross Lab, you can compare the effects of market volatilities on OliX PharmaceuticalsI and Green Cross and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OliX PharmaceuticalsI with a short position of Green Cross. Check out your portfolio center. Please also check ongoing floating volatility patterns of OliX PharmaceuticalsI and Green Cross.

Diversification Opportunities for OliX PharmaceuticalsI and Green Cross

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between OliX and Green is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding OliX PharmaceuticalsInc and Green Cross Lab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Green Cross Lab and OliX PharmaceuticalsI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OliX PharmaceuticalsInc are associated (or correlated) with Green Cross. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Green Cross Lab has no effect on the direction of OliX PharmaceuticalsI i.e., OliX PharmaceuticalsI and Green Cross go up and down completely randomly.

Pair Corralation between OliX PharmaceuticalsI and Green Cross

Assuming the 90 days trading horizon OliX PharmaceuticalsInc is expected to generate 2.14 times more return on investment than Green Cross. However, OliX PharmaceuticalsI is 2.14 times more volatile than Green Cross Lab. It trades about 0.11 of its potential returns per unit of risk. Green Cross Lab is currently generating about -0.07 per unit of risk. If you would invest  1,343,000  in OliX PharmaceuticalsInc on September 12, 2024 and sell it today you would earn a total of  1,172,000  from holding OliX PharmaceuticalsInc or generate 87.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

OliX PharmaceuticalsInc  vs.  Green Cross Lab

 Performance 
       Timeline  
OliX PharmaceuticalsInc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OliX PharmaceuticalsInc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, OliX PharmaceuticalsI sustained solid returns over the last few months and may actually be approaching a breakup point.
Green Cross Lab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Green Cross Lab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

OliX PharmaceuticalsI and Green Cross Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OliX PharmaceuticalsI and Green Cross

The main advantage of trading using opposite OliX PharmaceuticalsI and Green Cross positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OliX PharmaceuticalsI position performs unexpectedly, Green Cross can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Cross will offset losses from the drop in Green Cross' long position.
The idea behind OliX PharmaceuticalsInc and Green Cross Lab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance